摘要
目的了解子宫肌瘤患者接受腹腔镜子宫肌瘤剔除术治疗的临床疗效以及安全性分析。方法分析对象来自本院2018年3月至2018年6月收治12例用腹腔镜子宫肌瘤剔除术治疗的子宫肌瘤患者,对患者资料以回顾性方式分析并归纳腹腔镜子宫肌瘤剔除术对此类患者的应用价值。结果相对于治疗前患者的经期时间有所下降,血红蛋白指标有所上升,治疗前后指标经统计学软件处理提示差异明显(P<0.05);记录手术治疗期间术中出血量、手术时间和术后住院天数等指标,在相对令人满意的范围内;对患者进行随访并记录出现并发症、肌瘤复发情况,发生情况在可接受范围内。结论通过腹腔镜下子宫肌瘤剔除术手段对确诊为子宫肌瘤患者进行治疗,不但具有微创以及安全性高的特点,同时患者术后康复时间段且从长远考虑有助于防止复发情况,值得推广。
Objective To investigate the clinical efficacy and safety of uterine leiomyoma patients undergoing laparoscopic myomectomy. Methods From March 2018 to June 2018, 12 patients with uterine leiomyoma treated by laparoscopic myomectomy were analyzed retrospectively. The application value of laparoscopic myomectomy for these patients was summarized. Results The duration of menstruation decreased compared with that before treatment, hemoglobin index increased, the difference between the pre-treatment and post-treatment indicators was statistically significant (P<0.05);the intraoperative blood loss, operation time, and surgery were recorded during the surgery. After-hospital days and other indicators were within a relatively satisfactory range;patients were followed up and complications and recurrences of fibroids were recorded, and the occurrence was within an acceptable range. Conclusion Laparoscopic myomectomy is not only minimally invasive and safe, but also helpful to prevent recurrence in the long term.
作者
赵姝
ZHAO Shu(Gonghe County Hospital of Traditional Chinese Medicine, Hainan, Qinghai 813099)
出处
《智慧健康》
2019年第20期51-53,共3页
Smart Healthcare
关键词
腹腔镜
子宫肌瘤剔除术
术后康复
并发症
Laparoscopy
Myomectomy
Postoperative rehabilitation
Complications
